XML 26 R15.htm IDEA: XBRL DOCUMENT
v3.24.3

Fair Value of Financial Instruments | 9 Months Ended
--- | ---
Sep. 30, 2024
Investments, All Other Investments [Abstract] |
Fair Value of Financial Instruments | Note 7 – Fair Value of Financial Instruments The Company evaluates its financial assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level in which to classify them for each reporting period. This determination requires significant judgments to be made. SURGEPAYS, INC. AND SUBSIDIARIES NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS SEPTEMBER 30, 2024 The Company’s financial assets and liabilities measured at fair value on a recurring basis consisted of the following at September 30, 2024 and December 31, 2023, respectively: Financial Assets and Liabilities Measured at Fair Value
|  |  |  |  | Quoted Prices in Active Markets for |  |  | Significant Other Observable |  |  | Significant Unobservable |
|  |  |  |  | Identical Assets |  |  | Inputs |  |  | Inputs |
|  | September 30, 2024 |  |  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |
Exchange Traded Funds |  | $ | 10,068,506 |  |  | $ | 10,068,506 |  |  | $ | - |  |  | $ | - |
|  |  |  |  | Quoted Prices in Active Markets for |  |  | Significant Other Observable |  |  | Significant Unobservable |
|  |  |  |  | Identical Assets |  |  | Inputs |  |  | Inputs |
|  | December 31, 2023 |  |  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |
Exchange Traded Funds |  | $ | - |  |  | $ | - |  |  | $ | - |  |  | $ | - |

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration